Abstract:Triggering receptor expressed on myeloid cells 2 (TREM2) serves as an anti-inflammatory receptor, negatively regulating the innate immune response. TREM2 is mainly expressed on dendritic cells and macrophages, the target cells of porcine reproductive and respiratory syndrome virus (PRRSV). Thus, we investigated the potential role of TREM2 in PRRSV infection in porcine alveolar macrophages (PAMs). We found that there was an increased expression of TREM2 upon PRRSV infection in vitro. TREM2 silencing restrained the replication of PRRSV, whereas TREM2 overexpression facilitated viral replication. The cytoplasmic tail domain of TREM2 interacted with PRRSV Nsp2 to promote infection. TREM2 downregulation led to early activation of PI3K/NF-κB signaling, thus reinforcing the expression of proinflammatory cytokines and type I interferons. Due to the enhanced cytokine expression, a disintegrin and metalloproteinase 17 was activated to promote the cleavage of membrane CD163, which resulted in suppression of infection. Furthermore, exogenous soluble TREM2 (sTREM2)-mediated inhibition of PRRSV attachment might be attributed to its competitive binding to viral envelope proteins. In pigs, following PRRSV challenge in vivo, the expression of TREM2 in lungs and lymph nodes as well as the production of sTREM2 were significantly increased. These novel findings indicate that TREM2 plays a role in regulating PRRSV replication via the inflammatory response. Therefore, our work describes a novel antiviral mechanism against PRRSV infection and suggests that targeting TREM2 could be a new approach in the control of the PRRSV infection.Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most important pathogens in the global swine industry and is difficult to control. CD163 is a receptor that is required for PRRSV infection, and its expression is regulated by various inflammatory mediators. Triggering receptor expressed on myeloid cells 2 (TREM2) is a novel immunoregulatory receptor, which is involved in innate immunity and anti-inflammatory responses. Here we sought to elucidate whether TREM2 regulates CD163 expression to promote PRRSV infection via the inflammatory response. We found increased TREM2 levels upon PRRSV infection in vitro and in vivo in the lungs and lymph nodes of infected pigs. We demonstrated that the cytoplasmic tail of TREM2 interacts with PRRSV Nsp2 to promote infection. Additionally, TREM2 silencing triggers an early proinflammatory response via PI3K/NF-κB pathway, thus downregulating the expression of CD163, which leads to virus suppression. Our work provides a novel antiviral mechanism against PRRSV infection and suggests that targeting TREM2 could be a new approach for control of the disease.

TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection

TREM-2 promotes Th1 responses by interacting with the CD3ζ-ZAP70 complex following Mycobacterium tuberculosis infection

Bibliometric Analysis of TREM2 (2001-2022): Trends, Hotspots and Prospects in Human Disease

Advance of TREM-1 and Its Role in Sepsis

Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) Elicited by Lung Cancer Cells to Facilitate Tumor Immune Evasion.

Identification and Validation of TREM2 in Intracranial Aneurysms

Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance.

Activation of triggering receptor expressed on myeloid cells-1 protects monocyte from apoptosis through regulation of myeloid cell leukemia-1.

TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker

Function and mechanism of TREM2 in bacterial infection

TREM1: Activation, signaling, cancer and therapy

TREM2 suppresses the proinflammatory response to facilitate PRRSV infection via PI3K/NF-κB signaling

TREM2 is associated with tumor immunity and implies poor prognosis in glioma

TREM2 Activation Attenuates Neuroinflammation and Neuronal Apoptosis Via PI3K/Akt Pathway after Intracerebral Hemorrhage in Mice.

Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner.

Distinct roles of TREM2 in central nervous system cancers and peripheral cancers

TLR2 Senses the SARS-CoV-2 Envelope Protein to Produce Inflammatory Cytokines

Abstract 3555: TREM2 is Upregulated and Plays Oncogenic Role in Gastric Cancer

Triggering receptor expressed on myeloid cells-1 in sepsis, and current insights into clinical studies

TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy